Global Implantable Left Ventricular Assist Device Supply, Demand and Key Producers, 2023-2029

Global Implantable Left Ventricular Assist Device Supply, Demand and Key Producers, 2023-2029

The global Implantable Left Ventricular Assist Device market size is expected to reach $ 6502 million by 2029, rising at a market growth of 14.5% CAGR during the forecast period (2023-2029).

A left ventricular assist device (LVAD) is a pump that use for patients who have reached end-stage heart failure. We surgically implant the LVAD, a battery-operated, mechanical pump, which then helps the left ventricle (main pumping chamber of the heart) pump blood to the rest of the body. The LVAD pulls blood from the left ventricle into a pump. The pump then sends blood into the aorta (the large blood vessel leaving the left ventricle). This helps the weakened ventricle. The pump is placed in the upper part of the abdomen, while another tube attached to the pump is brought out of the abdominal wall to the outside of the body and attached to the pump's battery and control system.LVADs are now portable and can be used for many years. Patients with LVADs can be discharged from the hospital, return to their normal activities and enjoy a good quality of life while waiting for a donor heart to become available. Destination therapy patients, who are not transplant candidates, can also enjoy this same quality of life for years after implantation.

This report studies the global Implantable Left Ventricular Assist Device production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Implantable Left Ventricular Assist Device, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Implantable Left Ventricular Assist Device that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Implantable Left Ventricular Assist Device total production and demand, 2018-2029, (K Units)

Global Implantable Left Ventricular Assist Device total production value, 2018-2029, (USD Million)

Global Implantable Left Ventricular Assist Device production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Implantable Left Ventricular Assist Device consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Implantable Left Ventricular Assist Device domestic production, consumption, key domestic manufacturers and share

Global Implantable Left Ventricular Assist Device production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Implantable Left Ventricular Assist Device production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Implantable Left Ventricular Assist Device production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Implantable Left Ventricular Assist Device market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott(HeartMate）, SynCardia Systems, Berlin Heart, Johnson&Johnson(Abiomed), Jarvik Heart, ReliantHeart, Evaheart,Inc. and CH Biomedical,Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Implantable Left Ventricular Assist Device market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Implantable Left Ventricular Assist Device Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Implantable Left Ventricular Assist Device Market, Segmentation by Type
Bridge-To-Transplant Therapy
Destination Therapy

Global Implantable Left Ventricular Assist Device Market, Segmentation by Application
Hospital
Specialized Hospital
Other

Companies Profiled:
Medtronic
Abbott(HeartMate）
SynCardia Systems
Berlin Heart
Johnson&Johnson(Abiomed)
Jarvik Heart
ReliantHeart
Evaheart,Inc.
CH Biomedical,Inc.

Key Questions Answered

1. How big is the global Implantable Left Ventricular Assist Device market?

2. What is the demand of the global Implantable Left Ventricular Assist Device market?

3. What is the year over year growth of the global Implantable Left Ventricular Assist Device market?

4. What is the production and production value of the global Implantable Left Ventricular Assist Device market?

5. Who are the key producers in the global Implantable Left Ventricular Assist Device market?

6. What are the growth factors driving the market demand?